- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02633904
Investigation of the Femoral Shortening Osteotomy in the Developmental Dislocation of the Hip (FSODDH) (FSODDH)
December 16, 2015 updated by: He Jin Peng
Investigation of the Value of Femoral Shortening Osteotomy During Open Treatment of Developmental Dislocation of the Hip in Waliking Age Group
Although older children and high dislocations may be more likely to require a femoral shortening osteotomy, the ultimate decision about whether or not to shorten a given femur should depend on the ease of femoral head reduction in that specific patient.
Adding a femoral shortening procedure increases operating time and blood loss, adds a second incision, and necessitates future hardware removal.
In addition, an unnecessary femoral shortening osteotomy could overly decrease the soft tissue tension around the joint, putting the hip at risk for redislocation.
This study was designed to explore an algorithm based on strict age and radiographic criteria that identify those without the need of femoral osteotomy.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Developmental dislocation of the hip (DDH) is a common disease in children, and its incidence in China is about 9 ‰.There are many different methods in the treatment of DDH.
Although older children and high dislocations may be more likely to require a femoral shortening osteotomy, the ultimate decision about whether or not to shorten a given femur should depend on the ease of femoral head reduction in that specific patient.
Adding a femoral shortening procedure increases operating time and blood loss, adds a second incision, and necessitates future hardware removal.
In addition, an unnecessary femoral shortening osteotomy could overly decrease the soft tissue tension around the joint, putting the hip at risk for redislocation.
This study was designed to explore an algorithm based on strict age and radiographic criteria that identify those without the need of femoral osteotomy.
From the investigators'clinical experiences and the published papers, younger patients (<24 month of age) and low dislocations (Tonnis level I or II) were more likely to avoid a femoral shortening osteotomy.
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 2 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Unilateral DDH,age 18-24month.
- Tonnis degree I or II.
- Not receive any open treatment.
Exclusion Criteria:
- Teratologic hip dislocations,
- Patients with mental, neurological disorders (such as hypoxic-ischemic encephalopathy, epilepsy and dementia) or significant barriers to growth, cerebral palsy, multiple joint contractures disease, dysfunction of liver and kidney , blood disorders, immune deficiency disease and ECG abnormalities.
- Any children with prior hip surgery were excluded from the series.
- Parents refused further treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Osteotomy
Femoral osteotomy are applied in the open treatment of Developmental Dislocation of the Hip (DDH).
|
Femoral osteotomy are applied in the open treatment of Developmental Dislocation of the Hip (DDH).
|
|
Experimental: Non-osteotomy
Femoral osteotomy are not applied in the open treatment of Developmental Dislocation of the Hip (DDH).
|
Femoral osteotomy are not applied in the open treatment of Developmental Dislocation of the Hip (DDH).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Femur Head Necrosis
Time Frame: 2 years
|
Radiological evaluation was performed using standard anterior-posterior radiographs of the pelvis.
The presence and grade of femur head necrosis was evaluated according to the method presented by Bucholz and Odgen.
|
2 years
|
|
Redislocation
Time Frame: 2 years
|
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0.
|
2 years
|
|
Acetabular index
Time Frame: 2 years
|
Standardized radiographs have been traditionally used in the surveillance of hip dysplasia by measuring the acetabular index, which is the angle subtended between the Hilgenreiner line and a line drawn from the triradiate cartilage to the lateral edge of the acetabulum.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of operation
Time Frame: 1 month
|
The time during the operation measured by minute.
|
1 month
|
|
Blood loss
Time Frame: 1 month
|
The blood lost during the operation measured by milliliter.
|
1 month
|
|
Cost
Time Frame: 1 month
|
The cost of hospitalization.
|
1 month
|
|
Hospital stays
Time Frame: 1 month
|
The days stayed in hospital.
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Fan J Shao, Doctor, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Sankar WN, Tang EY, Moseley CF. Predictors of the need for femoral shortening osteotomy during open treatment of developmental dislocation of the hip. J Pediatr Orthop. 2009 Dec;29(8):868-71. doi: 10.1097/BPO.0b013e3181c29cb2.
- Pospischill R, Weninger J, Ganger R, Altenhuber J, Grill F. Does open reduction of the developmental dislocated hip increase the risk of osteonecrosis? Clin Orthop Relat Res. 2012 Jan;470(1):250-60. doi: 10.1007/s11999-011-1929-4. Epub 2011 Jun 4.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2015
Primary Completion (Anticipated)
December 1, 2018
Study Completion (Anticipated)
December 1, 2020
Study Registration Dates
First Submitted
December 10, 2015
First Submitted That Met QC Criteria
December 16, 2015
First Posted (Estimate)
December 17, 2015
Study Record Updates
Last Update Posted (Estimate)
December 17, 2015
Last Update Submitted That Met QC Criteria
December 16, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FSODDH
- He Jin Peng (Registry Identifier: Tongji Hospital)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
The single-center data will be published in the form of case-control study.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Femur Head Necrosis
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalActive, not recruitingAvascular Necrosis of Femur HeadTurkey (Türkiye)
-
Guangdong Provincial People's HospitalUnknownAvascular Necrosis of Femur Head
-
University Hospital, LilleTerminatedAseptic Necrosis of Femur HeadFrance
-
The First Affiliated Hospital of Xinxiang Medical...RecruitingAvascular Necrosis of Femur HeadChina
-
Banc de Sang i TeixitsEuropean Regional Development Fund; Ministerio de Sanidad, Servicios Sociales... and other collaboratorsCompleted
-
Erasme University HospitalUniversity of Liege; Bone Therapeutics S.ACompletedAvascular Necrosis of Femur HeadBelgium
-
Universidad Autonoma de MadridCompletedAvascular Necrosis of the Femoral HeadItaly, France, Germany, Spain
-
University Hospital, Basel, SwitzerlandWithdrawnAvascular Necrosis of the Femoral Head
-
R-BioSMG-SNU Boramae Medical CenterCompletedAvascular Necrosis of the Femoral HeadKorea, Republic of
-
Global Stem Cell Center, BaghdadCompletedAvascular Necrosis of the Femoral HeadIraq
Clinical Trials on Osteotomy
-
Istanbul UniversityRecruitingDevelopmental Dysplasia of the Hip | Acetabular Dysplasia | Developmental Dysplasia of the Hip (DDH)Turkey (Türkiye)
-
Hawler Medical UniversityRecruiting
-
Chang Gung Memorial HospitalUnknownCleft Lip and Palate | Le FortTaiwan
-
University Hospital, Basel, SwitzerlandCompletedKnee OsteoarthritisSwitzerland
-
Assiut UniversityUnknown
-
Hams Hamed AbdelrahmanCompleted
-
Sercan KüçükkurtCompletedDental Implant Surgery | Osteotomy ProtocolsTurkey (Türkiye)
-
University of MosulEnrolling by invitationDental Implant | Alveolar Bone Loss | Osseodensification Drilling TechniqueIraq
-
Hams Hamed AbdelrahmanCompleted
-
University of AarhusCompleted